June - 2022

NEWS

Ymmunobio to Present at the Annual Meeting of the Association for Cancer Immunotherapy (CIMT)

Ymmunobio Appoints New Chief Operating Officer

Ymmunobio Accepted into Innosuisse Core Coaching

Dr. Katrin Rupalla Interviewed by Global Business Reports

Drug Discovery & Development

Fierce Biotech: Appointment of Michel Janicot

BioPharma Dive

Ymmunobio Signs Collaboration Agreement with YUMAB https://www.biopharmadive.com/press-release/20220614-ymmunobio-signs-collaboration-agr...

Ymmunobio Signs Collaboration Agreement with YUMAB

RIEHEN, Switzerland — Ymmunobio to optimize its antibody development with YUMAB’s antibody technology Ymmunobio AG, a preclinical stage...